What’s new in diabetes drugs

Two classes of diabetes drugs—GLP-1 receptor agonists and SGLT-2 inhibitors—have received much attention lately. They not only lower blood sugar, they also help with weight reduction and may lower the risk of heart attack, stroke, and chronic kidney disease. The drugs can be taken as daily oral tablets or in some cases weekly injections, both of which are preferable over daily insulin shots.